Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 11;13:9043–9057. doi: 10.2147/OTT.S262084

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Nomogram and calibration curve for predicting PFS at 6- and 12-month for ES-SCLC patients. (A) Nomogram. The nomogram is used by adding the point identified on the points scale of each variable. The sum of points lies on the axis of Total Points, and corresponding to the percentage on the two axes at the bottom to indicate the 6- and 12-month PFS. (B) Calibration curve for 6-month PFS in training cohort; (C) Calibration curve for 12-month PFS in training cohort. (D) Calibration curve for 6-month PFS in validation cohort. (E) Calibration curve for 12-month PFS in validation cohort.

Abbreviations: PFS, progression-free survival; ES-SCLC, extensive-stage small-cell lung cancer; AAPR, albumin-to-alkaline phosphatase ratio.